Added to YB: 2024-10-01
Pitch date: 2024-09-28
BMY [neutral]
Bristol-Myers Squibb Company
+8%
current return
Author Info
Stock Pitckers Journey is the retired Director and COO of the Prudent Bear Funds. Sign up for the newsletter.
Company Info
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Market Cap
$105.2B
Pitch Price
$48.53
Price Target
N/A
Dividend
4.80%
EV/EBITDA
7.15
P/E
17.39
EV/Sales
2.90
Sector
Pharmaceuticals
Category
N/A
Confusion Inc. - Bristol-Myers Squibb - BMY
BMY (pass): Big Pharma facing chaos. Eliquis (25% sales, 40% profit) hit by CMS price cuts. Long-term guidance dropped, 'transition period' 2026-2030. Pipeline promising but dividend at risk. Debt from Celgene acquisition. 5% yield. Industry change or lobbyist win? Too uncertain to invest now.
Read full article (2 min)